CELH Stock Analysis: Celsius Holdings | NASDAQ

Energy Drinks, Hydration Powders, Powder Sticks, Wellness Products

Total Rating 49

Safety 83

Buy Signal -0.01

Beverages - Non-Alcoholic
Industry Rotation: +20.7

Market Cap: 7.60B
Avg Turnover: 153M

Risk 3d forecast

Volatility61.5%

VaR 5^th Pctl9.75%

VaR vs Median-3.66%

Reward TTM

Sharpe Ratio-0.37

Rel. Str. IBD45.7

Rel. Str. Peer Group13.6 pctl

Character TTM

Beta0.875

Beta Downside0.572

Hurst Exponent0.510

Choppyness46.2%

Drawdowns 3y

Max DD77.86%

CAGR/Max DD-0.23

CAGR/Mean DD-0.35

EPS (Earnings per Share)

EPS CAGR: 2.79%
EPS Trend: 4.6%

Last SUE: 0.28
Qual. Beats: 0

Revenue

Rev. CAGR: 43.85%
Rev. Trend: 91.3%

Last SUE: 1.04
Qual. Beats: 1

Warnings

Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.7 years of data

Jan +1.4% 5

Feb -4.1% 6

Mar -0.6% 7

Apr -0.5% 7

May +2.7% 11

Jun +1.4% 5

Jul -4.3% 6

Aug +8.3% 33

Sep -6.7% 47

Oct -0.9% 0

Nov +1.0% 13

Dec +1.6% 14

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: CELH Celsius Holdings

Celsius Holdings, Inc. (CELH) is a U.S.-based beverage company that develops, manufactures, and distributes functional energy drinks and hydration products across the United States, North America, Europe, Asia Pacific, and other international markets. Its portfolio includes ready-to-drink energy beverages, on-the-go powder sticks, and nutrition and wellness products marketed under the CELSIUS, Alani Nu, and Rockstar brand names. Sub-lines include CELSIUS ESSENTIALS, formulated with amino acids, and CELSIUS Hydration, a zero-sugar powder line featuring electrolytes.

The company sells through a broad omnichannel distribution network covering direct-to-store delivery, independent distributors, supermarkets, convenience stores, drug stores, nutritional and natural food stores, fitness centers, mass merchants, club stores, vitamin specialty stores, and e-commerce platforms. Founded in 2004 and headquartered in Boca Raton, Florida, the company was originally named Vector Ventures, Inc. before adopting its current name in January 2007. As a mid-cap stock in the Consumer Staples sector, Celsius operates within the Soft Drinks & Non-alcoholic Beverages sub-industry, targeting health- and fitness-oriented consumers through a portfolio of low- and zero-sugar functional drinks.

Headlines to Watch Out For

PepsiCo distribution partnership expands Celsius shelf space domestically
Energy drink market share gains accelerate against Monster and Red Bull
International expansion in Europe and Asia Pacific drives volume growth
Alani Nu acquisition diversifies portfolio toward female consumer segment

Piotroski VR-10 (Strict) 6.5

Net Income: 298.2m TTM > 0 and > 6% of Revenue
FCF/TA: 0.05 > 0.02 and ΔFCF/TA -4.72 > 1.0
NWC/Revenue: 29.30% < 20% (prev 42.93%; Δ -13.63% < -1%)
CFO/TA 0.06 > 3% & CFO 330.7m > Net Income 298.2m
Net Debt (-11.0m) to EBITDA (478.9m): -0.02 < 3
Current Ratio: 1.97 > 1.5 & < 3
Outstanding Shares: last quarter (254.9m) vs 12m ago 7.48% < -2%
Gross Margin: 47.64% > 18% (prev 51.38%; Δ -3.74% > 0.5%)
Asset Turnover: 60.84% > 50% (prev 40.37%; Δ 20.47% > 0%)
Interest Coverage Ratio: 9.30 > 6 (EBIT TTM 440.1m / Interest Expense TTM 47.3m)

Altman Z'' 2.65

A: 0.18 (Total Current Assets 1.89b - Total Current Liabilities 959.0m) / Total Assets 5.15b
B: 0.08 (Retained Earnings 425.8m / Total Assets 5.15b)
C: 0.08 (EBIT TTM 440.1m / Avg Total Assets 5.21b)
D: 0.60 (Book Value of Equity 1.28b / Total Liabilities 2.12b)
Altman-Z'' = 2.65 = A

Beneish M -2.72

DSRI: 0.87 (Receivables 666.6m/513.7m, Revenue 3.17b/2.13b)
GMI: 1.08 (GM 51.38% / 47.64%)
AQI: 0.99 (AQ_t 0.61 / AQ_t-1 0.62)
SGI: 1.49 (Revenue 3.17b / 2.13b)
TATA: -0.01 (NI 298.2m - CFO 330.7m) / TA 5.15b)
Beneish M = -2.72 (Cap -4..+1) = A

What is the price of CELH shares?

As of November 09, 2026, the stock is trading at USD 32.16 with a total of 8,185,279 shares traded. Over the past week, the price has changed by +10.44%, over one month by +17.85%, over three months by +35.30% and over the past year by -28.63%.

Current recommended Stop Loss: 29.20 (which is 9.2% or 2.1 ATR below the current price).

Is CELH a buy, sell or hold?

Celsius Holdings has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy CELH.

StrongBuy: 12
Buy: 6
Hold: 6
Sell: 0
StrongSell: 0

What are the forecasts/targets for the CELH price?

Analysts Target Price	41.1	27.8%

Celsius Holdings (CELH) - Fundamental Data Overview as of 08 November 2026

Market Cap USD = 7.60b (7.60b USD * 1.0 USD.USD)
P/E Trailing = 33.7528
P/E Forward = 17.762
P/S = 2.4944
P/B = 6.4863
P/EG = 0.2808
Revenue TTM = 3.17b USD
EBIT TTM = 440.1m USD
EBITDA TTM = 478.9m USD
Long Term Debt = 669.9m USD (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 689.6m USD (corrected: LT Debt 669.9m + ST Debt none) + Leases 19.7m
Net Debt = -11.0m USD (calculated: Debt 689.6m - CCE 700.6m)
Enterprise Value = 7.59b USD (7.60b + Debt 689.6m - CCE 700.6m)
Interest Coverage Ratio = 9.30 (Ebit TTM 440.1m / Interest Expense TTM 47.3m)
EV/FCF = 28.22x (Enterprise Value 7.59b / FCF TTM 269.0m)
FCF Yield = 3.54% (FCF TTM 269.0m / Enterprise Value 7.59b)
FCF Margin = 8.49% (FCF TTM 269.0m / Revenue TTM 3.17b)
Net Margin = 9.41% (Net Income TTM 298.2m / Revenue TTM 3.17b)
Gross Margin = 47.64% ((Revenue TTM 3.17b - Cost of Revenue TTM 1.66b) / Revenue TTM)
Gross Margin QoQ = 46.77% (prev 48.13%)
Tobins Q-Ratio = 1.47 (Enterprise Value 7.59b / Total Assets 5.15b)
Interest Expense / Debt = 6.86% (Interest Expense 47.3m / Debt 689.6m)
Taxrate = 19.26% (75.7m / 392.7m)
NOPAT = 355.3m (EBIT 440.1m * (1 - 19.26%))
Current Ratio = 1.97 (Total Current Assets 1.89b / Total Current Liabilities 959.0m)
Debt / Equity = 0.54 (Debt 689.6m / totalStockholderEquity, last quarter 1.28b)
Debt / EBITDA = -0.02 (Net Debt -11.0m / EBITDA 478.9m)
Debt / FCF = -0.04 (Net Debt -11.0m / FCF TTM 269.0m)
Total Stockholder Equity = 2.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.72% (Net Income 298.2m / Total Assets 5.15b)
RoE = 14.15% (Net Income TTM 298.2m / Total Stockholder Equity 2.11b)
RoCE = 15.85% (EBIT 440.1m / Capital Employed (Equity 2.11b + L.T.Debt 669.9m))
RoIC = 8.81% (NOPAT 355.3m / Invested Capital 4.03b)
WACC = 8.33% (E(7.60b)/V(8.29b) * Re(8.58%) + D(689.6m)/V(8.29b) * Rd(6.86%) * (1-Tc(0.19)))
Discount Rate = 8.58% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 62.10 | Cagr: 3.18%
[DCF] Terminal Value 73.10% ; FCFF base≈370.8m ; Y1≈325.2m ; Y5≈262.8m
[DCF] Fair Price = 16.71 (EV 4.22b - Net Debt -11.0m = Equity 4.23b / Shares 253.0m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 4.60 | EPS CAGR: 2.79% | SUE: 0.28 | # QB: 0
Revenue Correlation: 91.34 | Revenue CAGR: 43.85% | SUE: 1.04 | # QB: 1
EPS current Quarter (2027-03-31): EPS=0.40 | Chg30d=-2.57% | Revisions=-50% | Analysts=13
EPS current Year (2026-12-31): EPS=1.42 | Chg30d=-0.94% | Revisions=-50% | GrowthEPS=+5.8% | GrowthRev=+26.0%
EPS next Year (2027-12-31): EPS=1.70 | Chg30d=-2.07% | Revisions=-50% | GrowthEPS=+19.5% | GrowthRev=+8.5%
[Analyst] Revisions Ratio: -65% (up=2, down=15)